Voyager Therapeutics, Inc. SEC filings VYGR

Voyager Therapeutics, Inc. has 681 filings in SEC EDGAR's recent list, going back to Apr 23, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (officer or director change). The company's fiscal year ends on December 31.

Voyager Therapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 3, 2026 Nov 1, 2026
4 Insider transaction Nov 3, 2026 Nov 1, 2026
8-K Current report
Officer or director change
Oct 21, 2026 Oct 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
8-K Current report
Other events
Jul 13, 2026 Jul 13, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 10, 2026 Jun 9, 2026
8-K Current report
Other events
Jun 1, 2026 Jun 1, 2026
3 Initial insider ownership May 18, 2026 May 8, 2026
144 Notice of proposed sale May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
144 Notice of proposed sale May 15, 2026 —
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 9, 2026
8-K Current report
Officer or director change
Apr 21, 2026 Apr 15, 2026
PRE 14A Preliminary proxy statement Apr 10, 2026 Jun 9, 2026
4 Insider transaction Apr 3, 2026 Apr 2, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Results of operations
Mar 9, 2026 Mar 9, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
144 Notice of proposed sale Feb 24, 2026 —
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Officer or director change, Other events
Feb 12, 2026 Feb 9, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 11, 2026 Feb 10, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
144 Notice of proposed sale Feb 10, 2026 —
144 Notice of proposed sale Feb 10, 2026 —
144 Notice of proposed sale Feb 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 26, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
3 Initial insider ownership Jan 8, 2026 Jan 6, 2026
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 8, 2026
EFFECT Filing Dec 1, 2025 —
424B3 Prospectus Dec 1, 2025 —
CORRESP Letter to the SEC Nov 26, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
S-3 Shelf registration Nov 10, 2025 —
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
4 Insider transaction Oct 7, 2025 Oct 3, 2025
144 Notice of proposed sale Oct 3, 2025 —
144 Notice of proposed sale Oct 3, 2025 —
8-K Current report
Regulation FD disclosure
Sep 2, 2025 Sep 2, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
S-8 Employee stock plan registration Jun 9, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2025 —
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 23, 2025 —
DEF 14A Proxy statement Apr 23, 2025 Jun 3, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
S-8 Employee stock plan registration Mar 11, 2025 —
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
4 Insider transaction Feb 24, 2025 Feb 20, 2025
4 Insider transaction Feb 24, 2025 Feb 20, 2025
4 Insider transaction Feb 24, 2025 Feb 20, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
4 Insider transaction Feb 24, 2025 Feb 21, 2025
144 Notice of proposed sale Feb 20, 2025 —
144 Notice of proposed sale Feb 20, 2025 —
144 Notice of proposed sale Feb 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 12, 2025 Feb 11, 2025
4 Insider transaction Feb 12, 2025 Feb 11, 2025
4 Insider transaction Feb 12, 2025 Feb 11, 2025
4 Insider transaction Feb 12, 2025 Feb 11, 2025
144 Notice of proposed sale Feb 11, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
144 Notice of proposed sale Feb 11, 2025 —
8-K Current report
Other events
Feb 11, 2025 Feb 11, 2025
4 Insider transaction Jan 15, 2025 Jan 14, 2025
4 Insider transaction Jan 15, 2025 Jan 14, 2025
144 Notice of proposed sale Jan 14, 2025 —
144 Notice of proposed sale Jan 14, 2025 —
4 Insider transaction Dec 26, 2024 Dec 23, 2024
144 Notice of proposed sale Dec 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
4 Insider transaction Oct 3, 2024 Oct 2, 2024
144 Notice of proposed sale Oct 2, 2024 —
4 Insider transaction Oct 2, 2024 Oct 1, 2024
8-K Current report
Material agreement
Sep 5, 2024 Sep 3, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 7, 2024 —
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jul 9, 2024 Jul 8, 2024
3 Initial insider ownership Jul 9, 2024 Jul 8, 2024
8-K Current report
Officer or director change
Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 7, 2024 Jun 5, 2024
8-K Current report
Shareholder vote results
Jun 6, 2024 Jun 5, 2024
8-K Current report
Other events
May 16, 2024 May 16, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 5, 2024
4 Insider transaction Apr 3, 2024 Apr 1, 2024
4 Insider transaction Apr 3, 2024 Apr 2, 2024
4 Insider transaction Apr 3, 2024 Apr 2, 2024
8-K Current report
Officer or director change
Apr 2, 2024 Mar 27, 2024
144 Notice of proposed sale Apr 2, 2024 —
144 Notice of proposed sale Apr 2, 2024 —
4 Insider transaction Mar 26, 2024 Mar 25, 2024
3 Initial insider ownership Mar 26, 2024 Mar 25, 2024
8-K Current report
Other events
Mar 13, 2024 Feb 29, 2024
S-8 Employee stock plan registration Feb 28, 2024 —
10-K Annual report Feb 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
4 Insider transaction Feb 22, 2024 Feb 21, 2024
4 Insider transaction Feb 22, 2024 Feb 21, 2024
4 Insider transaction Feb 22, 2024 Feb 21, 2024
4 Insider transaction Feb 22, 2024 Feb 20, 2024
144 Notice of proposed sale Feb 21, 2024 —
144 Notice of proposed sale Feb 21, 2024 —
144 Notice of proposed sale Feb 21, 2024 —
144 Notice of proposed sale Feb 21, 2024 —
144 Notice of proposed sale Feb 20, 2024 —
4 Insider transaction Feb 16, 2024 Feb 9, 2024
4 Insider transaction Feb 16, 2024 Feb 9, 2024
4 Insider transaction Feb 16, 2024 Feb 9, 2024
4 Insider transaction Feb 16, 2024 Feb 9, 2024
4 Insider transaction Feb 16, 2024 Feb 9, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
4 Insider transaction Jan 19, 2024 Jan 17, 2024
4 Insider transaction Jan 19, 2024 Jan 17, 2024
D Filing Jan 17, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VYGR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Lexington, MA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1640266

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.